EZALLOR SPRINKLE

Sun Pharmaceutical Industries, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 16, 2023
Approval ID: 619add8c-3e39-4bb7-8828-450bd82c0404
Products: 4 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EZALLOR SPRINKLE safely and effectively. See full prescribing information for EZALLOR SPRINKLE. EZALLOR SPRINKLE (rosuvastatin) capsules, for oral use Initial U.S. Approval: 2003

Quick Stats

Total Products4

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.